Brian Andersen Email & Phone Number

Seattle, Washington, US

NA, CA

IGY Life Sciences & Technology Inc. is a privately held Biotechnology Company specializing in the development, extraction and commercialization of antibodies, or immunoglobulin (IgY), for use as OTC nutraceuticals and for development of specific vaccines. The company was formed in 2009 to commercialize a superior proprietary process for extraction of avian.

Miami Lakes, FL, US

Regentys (formerly Asana Medical) is focused on providing physicians with the first-in-class non-pharmacological, non-surgical treatment option for patients suffering from Ulcerative Colitis. Regentys’s device, derived from Extracellular Matrix, will set into motion a paradigm shift in the treatment of Inflammatory Bowel Disease (IBD) and other diseases.

Dublin, Ireland, IE

Helped to ensure a smooth transition of the Orphan Business Unit to the Group Vice President and General Manager taking on my previous role.

Dublin, Ireland, IE

After the acquisition of Vidara Therapeutics by Horizon Pharma, I was responsible for integrating the Vidara business into Horizon. As Group Vice President and General Manager of the Orphan Business Unit, I was responsible for the P&L and leading the members of the Orphan Business Unit. In addition, I worked closely with the medical team to put into place.

As a member of the founding team and VP, Sales and Marketing, I was responsible for the commercial due diligence for the acquisition of ACTIMMUNE®, for developing the launch business plan, building the reimbursement HUB (COMPASS), for putting into place the high-touch specialty pharmacy network, for creating the marketing materials for the relaunch of.

Seal Beach, CA, US

As Division Sales Manager, I managed a team of 7 oncology representatives and was responsible for sales of PROVENGE® (sipuleucel-T) in the Greater Chicago Area which consisted of most of Illinois, Indiana and most of Kentucky. We worked with both urologists and oncologists to provide PROVENGE®, an autologous cellular immunotherapy, as a treatment option.

South Barrington, Illinois, US

Worked closely with the CEO to conduct primary market research in the areas of pharmaceuticals, specialty pharmacy and managed care. After conducting the market research, worked to aggregate the information into a cohesive final report and recommendations to present to the client.

Valby, Copenhagen, DK

Responsible for the hospital and hematology products, including ATRYN® (antithrombin recombinant), PANHEMATIN® (hemin for injection) and NEOPROFEN® (ibuprofen lysine), as well as the commercial due diligence and launch planning on new product acquisitions. Our main products, ATRYN® and PANHEMATIN® both served ultra-orphan patient populations. We exceeded.

As the Director of Sales Training and Development, I was responsible for the CNS team product training for both XENAZINE® (tetrabenazine) and SABRIL® (vigabatrin), the area sales manager/director leadership development program, and compliance training for the commercial team. With my two training managers we develop the content for the launch meeting for.

Bedminster, New Jersey, US

As Product Director, CARDENE® I.V. (nicardipine I.V.), I was responsible for launching the CARDENE® I.V. line extension in the US during significant market change with two new market entrants a 505(b)(2) nicardipine and clevidipine emulsion. I developed the brand plan for launch of CARDENE® I.V (1x) RTU Bag.

US

Responsible for the sales of CARDENE® I.V. (nicardipine I.V.), RETAVASE® (reteplase), and I.V. BUSULFEX® (I.V. busulfan) in the Greater Chicago Region, consisting of 13 representatives and 8 states.

US

As a Regional Business Manager, I was responsible for the sales of CARDENE® I.V. (nicardipine I.V.), RETAVASE® (reteplase), and I.V. BUSULFEX® (I.V. busulfan) in the Greater Chicago Region, consisting of 13 representatives and 8 states. Prior to being promoted to Regional Business Manager, I relaunched Cardene I.V. in the Greater Chicago Area as one of the.

New York, New York, US

As a field representative, I was responsible for the sales of DETROL® (tolterodine) (launch in 1998), VANTIN® (cefpodoxime proxetil), DEPO-PROVERA® (medroxyprogesterone), and LUVOX® (fluvoxamine) in the North and Northwest Suburbs of Chicago where in 1998 I won the Premier Award (top selling award). In 1999, I was promoted to Institutional Sales.

Mba, Marketing & Finance

B.S., Biology

Education record